The Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to Rutgers’ RUCDR Infinite Biologics and its collaborators for a new collection approach that utilizes saliva as the primary test biomaterial for the SARS-CoV-2 coronavirus, the first such approval granted by the federal agency. “Saliva testing will help with the global shortage of swabs for sampling and increase testing […]
Recent Posts
- The HLA-B27 Gene: Key Implications for Dentistry and Sports Medicine- 1
- Revolutionizing Smiles: The Breakthrough That Could Make Cavities a Thing of the Past
- Mercury in Patients’ Mouths: Risks, Safe Amalgam Removal & Dentist Profits from the Global Phase-Out
- FDA’s Bold Move on Ingestible Fluoride: What Dentists Need to Know Globally
- When AI, Dentists, and Patients Don’t Agree: Who Decides What’s “Right” in Dental Care?
Archives